Dr Jeremy Mills
Biography
I am a senior lecturer in the School of Pharmacy and Biomedical Sciences.
Research interests
Pharmacogenetics, Regulation of drug metabolism, genetic polymorphism, Expression analysis of prostate cancer progression.
Research outputs
2025
Molecular docking, free energy calculations, ADMETox studies, DFT analysis, and dynamic simulations highlighting a chromene glycoside as a potential inhibitor of PknG in Mycobacterium tuberculosis
Alotaibi, H. A., Alrowily, M. J., Alruwaili, M., Alruwaili, Y., Althobiti, M. M., Elderdery, A. Y., Elsaman, T., Hamza, S. M. A., Mekki, S. E. I., Mills, J., Mohamed, M. A.
25 Feb 2025, In: Frontiers in Chemistry. 13, 18p., 1531152
2024
The influence of genetic polymorphisms in Cytochrome P450 (CYP1A1 and 2D6) gene on the susceptibility to Philadelphia Negative Chronic Myeloid Leukemia in Sudanese patients
Alenazy, F. O., Alruwaili, S. N. L., Alsrhani, A., Alzahrani, B., Elderdery, A. Y., Elkhalifa, A. M. E., Idris, H. M. E., Manni, E., Mills, J., Tebien, E. M.
17 Dec 2024, In: International Journal of Molecular Sciences. 25, 24, 11p., 13493
Genotyping and Characterizing Plasmodium falciparum to Reveal Genetic Diversity and Multiplicity of Infection by Merozoite Surface Proteins 1 and 2 (msp-1 and msp-2) and Glutamate-Rich Protein (glurp) Genes
Almutary, H., Alruwaili, M., Atif, M., Ejaz, H., Elderdery, A. Y., Farhana, A., Mills, J.
20 Nov 2024, In: Tropical Medicine and Infectious Disease. 9, 11, 11p., 284
Unveiling the anticancer potential: computational exploration of nitrogenated derivatives of (+)-Pancratistatin as Topoisomerase I inhibitors
Alotaibi, H. a., Alruwaili, M. M., Alsrhani, A., Elderdery, A. Y., Elsaman, T., Ghanem, H. B., Hamza, S. M. A., Mekki, S. E. I., Mills, J., Mohamed, M. A.
7 Oct 2024, In: International Journal of Molecular Sciences. 25, 19, 21p., 10779